Helix BioPharma Corp

HBP

Company Profile

  • Business description

    Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.

  • Contact

    40 Temperance Street
    Suite 2700, Bay Adelaide Centre - North Tower
    TorontoONM5H0B4
    CAN

    T: +1 604 684-2181

    https://www.helixbiopharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 July 2025

    Employees

    7

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,369.304.70-0.06%
CAC 407,698.8329.10-0.38%
DAX 4023,168.26176.28-0.76%
Dow JONES (US)41,218.8398.60-0.24%
FTSE 1008,588.507.85-0.09%
HKSE22,662.71158.030.70%
NASDAQ17,844.24133.49-0.74%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,421.090.16-0.00%
S&P 5005,650.3836.29-0.64%
S&P/ASX 2008,151.406.40-0.08%
SSE Composite Index3,316.1137.081.13%

Market Movers